BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Amniocentesis, Aspirin, rs4950928, IL1A, glucose metabolic process, Allergy to pollen)
Bookmark Forward

QuickView for TLR9 (gene)


Body Atlas

Most Correlated Tissues

  1. Tonsil
  2. Rectum colon
  3. Ascending colon
  4. Pancreas
  5. Sigmoid colon
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Coronavirus infection
  2. Infection due to Haemophilus
  3. Viral carditis
  4. Disease due to Rotavirus
  5. Influenza
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Salivary Cystatins
  2. diethyl maleate
  3. Acriflavine
  4. Oligodeoxyribonucleotides
  5. 5-(6)-carboxyfluorescein diacetate succinimidyl ester
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. TLR9
  2. DDX17
  3. EN1
  4. ABCC5
  5. DPRX
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Intestinal serotonergic system is modulated by Toll-like receptor 9.
  2. Coevolutionary Analysis Implicates Toll-Like Receptor 9 in Papillomavirus Restriction.
  3. Transcriptome changes upon Toll-like receptor 9 pathway activation in primary renal tubular epitheli…
  4. Immunotherapy of Malignant Glioma by Noninvasive Administration of TLR9 Agonist CpG Nano-Immunoadjuv…
  5. The Biology of Toll-Like Receptor 9 and Its Role in Cancer.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. TLR9 Agonist SD-101, Anti-OX40 Antibody BMS 986178, and Radiation Therapy in Treating Patients With …
  2. TLR9 Agonist SD-101, Ibrutinib, and Radiation Therapy in Treating Patients With Relapsed or Refracto…
  3. Innate Immunity Stimulation Via TLR9 in Early AD
  4. Combining TLR9 Agonist With bNAbs for Reservoir Reduction and Immunological Control of HIV
  5. CYT003-QbG10, a TLR9-agonist, for Treatment of Uncontrolled Moderate to Severe Allergic Asthma
Explore Clinical Trials Results
  • Copyright © 2023 Illumina Inc. All rights reserved.